Repligen (RGEN)
180.01
0.00 (0.00%)
Upcoming Events
Latest Headlines
Repligen (RGEN) PT Raised to $180 at Canaccord
October 19, 2026 7:51 AM - StreetInsider
Repligen to Report Third Quarter 2026 Financial Results
October 13, 2026 7:30 AM - Globe NewsWire
Form 4 REPLIGEN CORP For: Oct 06 Filed by: Douglass Brian Robb
October 8, 2026 4:40 PM - SEC Filing
Form SCHEDULE 13G/A REPLIGEN CORP Filed by: FMR LLC
October 7, 2026 11:47 AM - SEC Filing
Repligen (RGEN) PT Raised to $225 at Barclays
October 7, 2026 3:51 AM - StreetInsider
Form 4 REPLIGEN CORP For: Oct 05 Filed by: Loeillot Olivier
October 6, 2026 4:18 PM - SEC Filing
Form 8-K REPLIGEN CORP For: Oct 06
October 6, 2026 9:15 AM - SEC Filing
Repligen completes acquisition of BioLife Solutions for cash and stock
October 6, 2026 9:05 AM - StreetInsider
Repligen Completes Acquisition of BioLife Solutions
October 6, 2026 9:05 AM - Globe NewsWire
Freshworks Set to Join S&P SmallCap 600
October 5, 2026 6:30 PM - PR NewsWire
Freshworks to join S&P SmallCap 600 index
October 5, 2026 5:18 PM - StreetInsider
Form 144 REPLIGEN CORP Filed by: Loeillot Olivier
October 5, 2026 4:11 PM - SEC Filing
Form 4 REPLIGEN CORP For: Oct 02 Filed by: Loeillot Olivier
October 5, 2026 4:01 PM - SEC Filing
Form 144 REPLIGEN CORP Filed by: Loeillot Olivier
October 5, 2026 1:14 PM - SEC Filing
KeyBanc's Preview of 'Biggest Potential Beats in Life Science'
October 5, 2026 8:40 AM - StreetInsider
UBS Reiterates Buy Rating on Repligen (RGEN) as Incrementally Positive on Outlook
September 29, 2026 9:02 AM - StreetInsider
Form 4 REPLIGEN CORP For: Sep 25 Filed by: Garland Jason K
September 28, 2026 4:06 PM - SEC Filing
Form 4 REPLIGEN CORP For: Sep 24 Filed by: Loeillot Olivier
September 25, 2026 4:10 PM - SEC Filing
Form 144 REPLIGEN CORP Filed by: Loeillot Olivier
September 24, 2026 5:05 PM - SEC Filing
Form 4 REPLIGEN CORP For: Sep 21 Filed by: Loeillot Olivier
September 22, 2026 4:07 PM - SEC Filing
Form 144 REPLIGEN CORP Filed by: Loeillot Olivier
September 21, 2026 3:04 PM - SEC Filing
Form 8-K REPLIGEN CORP For: Sep 10
September 15, 2026 4:04 PM - SEC Filing
UBS Assumes Repligen (RGEN) at Buy
September 9, 2026 6:08 AM - StreetInsider
Repligen (RGEN) PT Raised to $210 at HSBC
September 1, 2026 2:16 AM - StreetInsider
Repligen Corporation to Present at Wells Fargo 21st Annual Healthcare Conference
August 26, 2026 7:30 AM - Globe NewsWire
Form S-4 REPLIGEN CORP
August 25, 2026 6:04 AM - SEC Filing
Form 4 REPLIGEN CORP For: Aug 20 Filed by: Loeillot Olivier
August 21, 2026 4:06 PM - SEC Filing
Form 144 REPLIGEN CORP Filed by: Loeillot Olivier
August 20, 2026 11:54 AM - SEC Filing
Repligen (RGEN) call put ratio 5.6 calls to 1 put
August 19, 2026 11:23 AM - StreetInsider
Repligen (RGEN) call put ratio 1 call to 6.7 puts into share price up before the bell
August 19, 2026 9:12 AM - StreetInsider
Form SCHEDULE 13G/A REPLIGEN CORP Filed by: PRICE T ROWE ASSOCIATES INC /MD/
August 14, 2026 10:39 AM - SEC Filing
Form SCHEDULE 13G REPLIGEN CORP Filed by: VANGUARD CAPITAL MANAGEMENT LLC
July 31, 2026 10:46 AM - SEC Filing
Repligen (RGEN) PT Raised to $185 at Wells Fargo
July 30, 2026 8:35 AM - StreetInsider
Form 10-Q REPLIGEN CORP For: Jun 30
July 29, 2026 4:21 PM - SEC Filing
Repligen (RGEN) PT Raised to $175 at JPMorgan
July 29, 2026 8:55 AM - StreetInsider
Canaccord Reiterates Hold Rating on Repligen (RGEN)
July 29, 2026 6:47 AM - StreetInsider
Repligen (RGEN) PT Raised to $185 at RBC Capital
July 29, 2026 6:21 AM - StreetInsider
Repligen (RGEN) PT Raised to $160 at Wolfe Research
July 29, 2026 5:35 AM - StreetInsider
Repligen (RGEN) PT Raised to $160 at Jefferies
July 28, 2026 1:21 PM - StreetInsider
Form 8-K REPLIGEN CORP For: Jul 28
July 28, 2026 7:14 AM - SEC Filing
Repligen (RGEN) Tops Q2 EPS by 9c ; Offers Guidance
July 28, 2026 7:11 AM - StreetInsider
Repligen Reports Second Quarter 2026 Financial Results and Updates Full Year 2026 Financial Guidance
July 28, 2026 7:00 AM - Globe NewsWire
Full Article List
